Navigation Links
ImaginAb, Inc. Awarded $2.3 Million from the National Cancer Institute
Date:10/31/2011

LOS ANGELES, Oct. 31, 2011 /PRNewswire/ -- ImaginAb, Inc. is pleased to announce that it has been awarded a total of $2.3 million in funding from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) program to help further develop diagnostic imaging agents for Positron Emission Tomography (PET). Over the past 20 years, PET has evolved into a powerful and highly valued tool for the clinical management of cancer but many important areas of oncology still lack effective diagnostic and staging tools – particularly pancreatic and prostate cancer. It is estimated that over 70,000 people in the United States alone die of pancreatic and prostate cancer annually. ImaginAb's Head of Pre-Clinical Development, Dr. David Ho, will be the Principal Investigator in close collaboration with Dr. David Colcher at the City of Hope (Duarte, CA). ImaginAb will use this funding over the next two years to further accelerate its clinical program.

"The NCI SBIR program has become a very important source of financing for early-stage oncology companies, particularly considering the lack of risk capital available and changes in the early stage venture capital landscape over the past few years," noted Dr. Christian Behrenbruch, CEO of ImaginAb. "These funds from the NCI will be invested alongside ImaginAb resources to help drive our prostate and pancreatic oncology program ahead even more aggressively. The NCI has been a true partner in helping move our technology forward and have provided not only funding, but also access to clinical expertise and relationships with potential investors and pharma."

"For a company the size of ImaginAb, the NCI SBIR program is an invaluable source of funds that will greatly help with moving our lead products closer to commercialization," commented Jenny Keppler, ImaginAb's President and Chief Operating Officer.  "The highly competitive and peer-reviewed nature of NCI funding ensures that the most promising research is given an opportunity for development and commercialization."

About ImaginAb, Inc.

Founded in 2007 by UCLA Faculty (Drs. Robert Reiter, Anna Wu and Christian Behrenbruch), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody products. For more information about ImaginAb, visit www.imaginab.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Anna Wu

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91513


'/>"/>
SOURCE ImaginAb, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
2. ImaginAb, Inc. and Dainippon Seiki (DNS) Co., Ltd. Conclude Technology Development Agreement for Automated Chemistry Systems
3. ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia
4. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
5. Bacterin Awarded Approved Vendor Status for American Medical Concepts Network of Hospitals in the Northwest U.S.
6. Darah Medical Awarded GSA Schedule, Launches Online Store
7. SensoScientific Awarded Contract by Premier Health Care Alliance for its Breakthrough WI-FI Temperature Monitoring System
8. MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
9. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
10. STELARA® Awarded 2011 Prix Galien USA in Best Biotechnology Product Category
11. University of Michigan Pediatric Device Inventors Awarded Funds to Design Child-Specific Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... Laboratories, LLC Chief Science Officer, Dr. Adam Elhofy , will be ... Cell-Ess® Universal Titer Boost at the 9 th annual ... The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share ... Cell-Ess ... Cell-Ess is the world,s ...
(Date:8/15/2017)... Aug. 15, 2017  AOTI Inc. announced today that its fully ... has recently opened a New York City Office in ... its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This ... Commission for Health Care (ACHC) under the company,s DMEPOS accreditation for ... ...
(Date:8/8/2017)...   Second-quarter 2017 revenues of ... share from continuing operations ... to $110 million Second-quarter ... million Second-quarter 2017 adjusted ... 8 percent to $0.93 ...
Breaking Medicine Technology:
(Date:8/18/2017)... Morgantown, WV (PRWEB) , ... August 18, 2017 ... ... offers financial consulting services and asset protection assistance to communities in North-Central West ... to provide critical services to at-risk boys in the area. , The Chestnut ...
(Date:8/18/2017)... Saint John, IN (PRWEB) , ... August 18, 2017 , ... ... services to communities in northwest Indiana, is campaigning in support of Campagna Academy in ... Formerly referred to as the “Hoosier Boys’ Town of Indiana,” Campagna Academy is a ...
(Date:8/18/2017)... ... 18, 2017 , ... “Emotions are sacred, valid, honored, encouraged. This is the ... company Generation Mindful. To help change the mindset of parents and educators from punitive ... created the Time-In Toolkit, which launched on Kickstarter 3 weeks ago and fully funded ...
(Date:8/18/2017)... Boca Raton (PRWEB) , ... August 18, 2017 , ... ... is continuing to ramp up its marketing efforts with its product now available through ... hangover remedy to the public. The effervescent powdered drink is designed to quickly detox ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Our Mountains to Climb: ... of a couple that grew stronger together through the faith they shared to overcome ... Trials” is the creation of published author, Barbara J. Corcoran, a retired teacher and ...
Breaking Medicine News(10 mins):